Earn CME: https://www.naccme.com/program/19-lm-13 In this webcast from the ‘Treatment for Marginal Zone Lymphoma: Should it be Different from FL?’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Thomas M. Habermann discusses the treatment of marginal zone lymphoma (MZL). © 2019 Imedex, an HMP Company
Panel Discussion: Marginal Zone Lymphoma
